MedPath

The effect of L-Citrulline in type 2 Diabetes

Phase 3
Conditions
Type 2 diabetes.
Type 2 diabetes mellitus
Registration Number
IRCT20100209003320N16
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
46
Inclusion Criteria

Suffering from type 2 diabetes that have passed at least 6 months since diagnosis and having HbA1c less than 9.
Men and non-menopausal women
Age 25 to 55 years
BMI 25 to 35 kg/m2
People who control their diabetes just by using metformin and sulfonylurea
Willingness to participate in the study

Exclusion Criteria

Pregnancy, lactation or menopause in women
Smoking or alcohol use
A history of following a particular diet (at the time of the study or 3 months before the study)
Change in the type or dosage of medications consumed, the type and amount of physical activity, changes in the diet at the start and during the study
Using synthetic or herbal drugs for weight loss
Use of any supplement (L-arginine, glutamine, multivitamin, antioxidant supplement, etc.) during the three months before or during the study.
Taking insulin
Suffering from cardiovascular disease, liver, intestinal, thyroid and parathyroid dysfunction, polycystic ovary syndrome, cancers and malignant diseases such as sprue and Crohn's disease
Having symptoms of infectious or inflammatory disease or recent surgery
The use of hypotensive and lipid-lowering drugs
Use of corticosteroids and non-steroidal anti-inflammatory drugs for 3 months before the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath